Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Cancer. 2010 Feb 1;116(3):659–669. doi: 10.1002/cncr.24831

Figure 5.

Figure 5

Survival analysis based on individual histologic parameters. (A) The overall survival was significantly better for patients with tumors with a solid growth <90% than for patients with tumors with >90% solid growth (P=0.046). Patients with tumors with a solid growth <90% had a median overall survival of 69.4 months and those with tumors with >90% solid growth had a median overall survival of 21.4 months. (B) The overall survival was significantly better for patients with tumors with mild/moderate cytologic atypia as compared with patients with tumors with severe atypia (P=0.01). The median overall survival was 71.0 months for patients with tumors with mild/moderate cytologic atypia and 30.5 months for patients with tumors with severe cytologic atypia. The overall survival was the same for patients with tumors with mild/moderate cytologic atypia (P=0.74). (C) The overall survival was not significantly different between patients with tumors with ≤13 mitoses/10 HPF and patients with >13 mitoses/10 HPF (P=0.26).